Brokerages Set BKV Corporation (NYSE:BKV) Price Target at $28.25

Shares of BKV Corporation (NYSE:BKV - Get Free Report) have received an average rating of "Buy" from the eight brokerages that are covering the stock, Marketbeat reports. Eight investment analysts have rated the stock with a buy rating. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $28.25.

Several research firms have recently commented on BKV. Barclays raised their price target on BKV from $29.00 to $30.00 and gave the company an "overweight" rating in a report on Monday, July 7th. Evercore ISI raised their price target on BKV from $20.00 to $26.00 and gave the company an "outperform" rating in a report on Friday, May 30th.

BKV Stock Down 2.5%

BKV stock traded down $0.51 during mid-day trading on Wednesday, reaching $19.72. 182,855 shares of the company were exchanged, compared to its average volume of 455,947. BKV has a twelve month low of $15.00 and a twelve month high of $26.78. The firm's 50-day simple moving average is $22.46 and its two-hundred day simple moving average is $21.54. The company has a quick ratio of 0.39, a current ratio of 0.41 and a debt-to-equity ratio of 0.13.

BKV (NYSE:BKV - Get Free Report) last posted its quarterly earnings results on Friday, May 9th. The company reported $0.41 EPS for the quarter, beating the consensus estimate of $0.15 by $0.26. The business had revenue of $216.13 million during the quarter, compared to analyst estimates of $223.20 million. Research analysts forecast that BKV will post -1.82 earnings per share for the current fiscal year.

Insider Buying and Selling

In other BKV news, insider Eric S. Jacobsen sold 31,350 shares of the firm's stock in a transaction on Monday, May 19th. The stock was sold at an average price of $22.02, for a total transaction of $690,327.00. Following the completion of the transaction, the insider owned 257,903 shares of the company's stock, valued at approximately $5,679,024.06. This trade represents a 10.84% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Lindsay B. Larrick sold 10,000 shares of the firm's stock in a transaction on Tuesday, July 1st. The stock was sold at an average price of $23.13, for a total value of $231,300.00. Following the transaction, the insider directly owned 210,528 shares of the company's stock, valued at $4,869,512.64. The trade was a 4.53% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 217,208 shares of company stock worth $4,695,833. 4.11% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On BKV

A number of hedge funds and other institutional investors have recently made changes to their positions in BKV. Driehaus Capital Management LLC purchased a new position in shares of BKV in the 4th quarter worth about $9,553,000. Geode Capital Management LLC purchased a new position in shares of BKV in the 4th quarter worth about $7,728,000. Quantbot Technologies LP purchased a new position in shares of BKV in the 1st quarter worth about $1,605,000. Bank of New York Mellon Corp raised its holdings in shares of BKV by 21.2% in the 1st quarter. Bank of New York Mellon Corp now owns 35,453 shares of the company's stock worth $745,000 after purchasing an additional 6,209 shares during the period. Finally, Corebridge Financial Inc. purchased a new position in shares of BKV in the 4th quarter worth about $170,000.

About BKV

BKV Corporation engages in the acquisition, operation, and development of natural gas and NGL properties. It is also involved in the gathering, processing, and transportation of natural gas. The company was founded in 2015 and is based in Denver, Colorado with additional offices in Tunkhannock, Pennsylvania and Fort Worth, Texas.